Literature DB >> 12194994

Effect of beta propiolactone viral inactivation on alpha1 antitrypsin values.

S J Katona1, M Bowen, E R Kaminski.   

Abstract

AIMS: alpha1 Antitrypsin was undetectable in several patient samples treated with 0.5% beta propiolactone, which was used as a virucidal agent. This study was designed to confirm beta propiolactone as the cause and determine why it might have such an effect.
METHODS: Volumes of 0, 5, 10, and 20 micro l of beta propiolactone were added to 2 ml aliquots of serum to make final concentrations of 0%, 0.25%, 0.5%, and 1% of beta propiolactone. alpha1 Antitrypsin concentrations and the pH were measured at different time intervals. The effects of adding buffer before the addition of beta propiolactone, NaOH after beta propiolactone, and 6M HCl instead of beta propiolactone were also measured.
RESULTS: The addition of beta propiolactone to a volunteer's serum showed a fall in both alpha1 antitrypsin values and pH with increasing time and concentration of beta propiolactone. This effect was also seen when adding HCl, but was partially prevented by buffering the serum or adding NaOH.
CONCLUSIONS: These results suggest that it is the acidity of the degradation products of beta propiolactone that is responsible for the fall in alpha1 antitrypsin values. This fall in alpha1 antitrypsin values was dependent on the concentration of beta propiolactone used and the length of time before the test was performed. The effect of beta propiolactone on laboratory tests should be re-evaluated, with attention being paid to sample pH, storage time, and storage temperature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194994      PMCID: PMC1769741          DOI: 10.1136/jcp.55.9.659

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity.

Authors:  A E Mast; J E Stadanlick; J M Lockett; D J Dietzen
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

2.  beta-Propiolactone: viral inactivation in vaccines and plasma products.

Authors:  S A Lawrence
Journal:  PDA J Pharm Sci Technol       Date:  2000 May-Jun

3.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

4.  Effect of beta-propiolactone on some routine haematological tests.

Authors:  H I Atrah; M Allardyce; R J Davidson
Journal:  Med Lab Sci       Date:  1988-10

5.  Beta-propiolactone UV inactivated clotting factor concentrate is the source of HIV-infection of 8 hemophilia B patients: confirmed.

Authors:  B Kupfer; J Oldenburg; H H Brackmann; B Matz; K E Schneweis; R Kaiser
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

6.  Evaluation by polymerase chain reaction on the effect of beta-propiolactone and binary ethyleneimine on DNA.

Authors:  C Groseil; P Guerin; P Adamowicz
Journal:  Biologicals       Date:  1995-09       Impact factor: 1.856

7.  The citrate ion increases the conformational stability of alpha(1)-antitrypsin.

Authors:  S P Bottomley; D J Tew
Journal:  Biochim Biophys Acta       Date:  2000-08-31

8.  Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro.

Authors:  G Herbein; P Illei; L J Montaner; W James; S Gordon
Journal:  J Virol Methods       Date:  1996-04-26       Impact factor: 2.014

9.  In vitro amyloid fibril formation from alpha 1-antitrypsin.

Authors:  S Janciauskiene; E Carlemalm; S Eriksson
Journal:  Biol Chem Hoppe Seyler       Date:  1995-02

10.  Effect of beta-propiolactone--an inhibitor of HTLV III/LAV activity--on immunological analyses.

Authors:  M J Ball; V Spriggs; P M Sutton; H Chapel
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.